Publication | Open Access
Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2–negative advanced breast cancer: final overall survival results from SOLAR-1
557
Citations
26
References
2020
Year
NCT02437318.
| Year | Citations | |
|---|---|---|
Page 1
Page 1